Ebticem NOURI

Ebticem Nouri has a range of work experience in the field of life sciences. Ebticem'smost recent role was as an In vivo Pharmacology Scientist at Calliditas Therapeutics AB, where they were involved in pre-clinical project management and in vivo model development. Ebticem also gained experience in molecular and biochemical techniques and participated in internal and external scientific communications. Prior to this, they worked as a Researcher Junior - PhD student at Clevexel Pharma, focusing on the link between metabolic hormones and neoplastic transformation. Ebticem has also held internship positions at the Centre de recherche en cancérologie de Lyon, where they studied the role of metabolic hormones in stemness features and pro-apoptotic signaling of the TrkC dependence receptor. Ebticem has also worked as a laboratory technician at the Cantonal Hospital of Geneva. Overall, Nouri has a strong background in research and a range of scientific skills, including in vivo model development, molecular techniques, and laboratory work.

Ebticem Nouri's education history begins in 2008 when they enrolled at Université Claude Bernard Lyon 1. From 2008 to 2010, they pursued a Technological University degree (DUT) with a specialization in biological engineering. Following this, from 2010 to 2011, Ebticem obtained their Bachelor's degree in Biology from the same university. They continued their studies at Université Claude Bernard Lyon 1, completing a Master's degree in Genetic, Cell Biology and Pathologies from 2011 to 2013. Finally, Ebticem pursued a Research Doctorate in Cell & molecular biology and oncology at Université Claude Bernard Lyon 1 from 2013 to 2017.